Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma

Front Oncol. 2023 Jul 14:13:1220063. doi: 10.3389/fonc.2023.1220063. eCollection 2023.

Tsung-I Hsu^{1

2

3

4}

¹ Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, Taiwan.
² International Master Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
³ Taipei Medical University Research Center of Neuroscience, Taipei, Taiwan.
⁴ Taipei Medical University Research Center of Cancer Translational Medicine, Taipei, Taiwan.

No abstract available

Keywords: flavins; glioblastoma; mass spectrometry; metabolic reprogramming; orexin A; succinylation; temozolomide; therapeutic resistance.

Publication types

T-IH is supported by the grant NSTC111-2320-B-038-060- from National Science and Technology Council of Taiwan.